Loading clinical trials...
Loading clinical trials...
A Genotype-guided Dosing Study of mFOLFIRINOX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies
Conditions
Interventions
oxaliplatin
irinotecan hydrochloride
+3 more
Locations
2
United States
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
Evanston CCOP-NorthShore University HealthSystem
Evanston, Illinois, United States
Start Date
March 26, 2012
Primary Completion Date
August 28, 2016
Completion Date
July 1, 2019
Last Updated
May 8, 2020
NCT02047474
NCT01835041
NCT02333188
NCT00981162
NCT00031694
NCT00478140
Lead Sponsor
University of Chicago
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions